150 related articles for article (PubMed ID: 35880752)
41. Identification and validation of an immune prognostic signature in colorectal cancer.
Li M; Wang H; Li W; Peng Y; Xu F; Shang J; Dong S; Bu L; Wang H; Wei W; Hu Q; Liu L; Zhao Q
Int Immunopharmacol; 2020 Nov; 88():106868. PubMed ID: 32771948
[TBL] [Abstract][Full Text] [Related]
42. A signature based on 11 autophagy genes for prognosis prediction of colorectal cancer.
Chen S; Wang Y; Wang B; Zhang L; Su Y; Xu M; Zhang M
PLoS One; 2021; 16(10):e0258741. PubMed ID: 34699544
[TBL] [Abstract][Full Text] [Related]
43. A five-immune-related genes-based prognostic signature for colorectal cancer.
Zhu L; Wang H; Wang Z
Int Immunopharmacol; 2020 Nov; 88():106866. PubMed ID: 32781411
[TBL] [Abstract][Full Text] [Related]
44. Identification of a Novel Five-Gene Signature as a Prognostic and Diagnostic Biomarker in Colorectal Cancers.
Ghatak S; Mehrabi SF; Mehdawi LM; Satapathy SR; Sjölander A
Int J Mol Sci; 2022 Jan; 23(2):. PubMed ID: 35054980
[TBL] [Abstract][Full Text] [Related]
45. Identification and Validation of a Six Immune-Related Genes Signature for Predicting Prognosis in Patients With Stage II Colorectal Cancer.
Li X; Xie M; Yin S; Xiong Z; Mao C; Zhang F; Chen H; Jin L; Lan P; Lian L
Front Genet; 2021; 12():666003. PubMed ID: 34017356
[TBL] [Abstract][Full Text] [Related]
46. A 16-mRNA signature optimizes recurrence-free survival prediction of Stages II and III gastric cancer.
Peng K; Chen E; Li W; Cheng X; Yu Y; Cui Y; Li Q; Wang Y; Xu X; Tang C; Gan L; Yu S; Liu T
J Cell Physiol; 2020 Jul; 235(7-8):5777-5786. PubMed ID: 32048287
[TBL] [Abstract][Full Text] [Related]
47. Concomitant dysregulation of the estrogen receptor and BRAF/MEK signaling pathways is common in colorectal cancer and predicts a worse prognosis.
Liu D
Cell Oncol (Dordr); 2019 Apr; 42(2):197-209. PubMed ID: 30645729
[TBL] [Abstract][Full Text] [Related]
48. Interrogation of ERG gene rearrangements in prostate cancer identifies a prognostic 10-gene signature with relevant implication to patients' clinical outcome.
Bismar TA; Alshalalfa M; Petersen LF; Teng LH; Gerke T; Bakkar A; Al-Mami A; Liu S; Dolph M; Mucci LA; Alhajj R
BJU Int; 2014 Feb; 113(2):309-19. PubMed ID: 24006850
[TBL] [Abstract][Full Text] [Related]
49. Comprehensive Transcriptomic Analysis Reveals Prognostic Value of an EMT-Related Gene Signature in Colorectal Cancer.
Mo S; Dai W; Zhou Z; Gu R; Li Y; Xiang W; Han L; Zhang L; Wang R; Cai G; Cai S; Gan L; Li Q
Front Cell Dev Biol; 2021; 9():681431. PubMed ID: 34211976
[TBL] [Abstract][Full Text] [Related]
50. Discovery of a novel six-long non-coding RNA signature predicting survival of colorectal cancer patients.
Fan Q; Liu B
J Cell Biochem; 2018 Apr; 119(4):3574-3585. PubMed ID: 29227531
[TBL] [Abstract][Full Text] [Related]
51. Establishment of a circular RNA regulatory stemness-related gene pair signature for predicting prognosis and therapeutic response in colorectal cancer.
Chen Q; Tang P; Huang H; Qiu X
Front Immunol; 2022; 13():934124. PubMed ID: 35958575
[TBL] [Abstract][Full Text] [Related]
52. Development and validation of a novel miRNA classifier as a prognostic signature for stage II/III colorectal cancer.
Feng J; Wei Q; Yang M; Wang X; Liu B; Li J
Ann Transl Med; 2021 May; 9(9):747. PubMed ID: 34268360
[TBL] [Abstract][Full Text] [Related]
53. Deep learning with whole slide images can improve the prognostic risk stratification with stage III colorectal cancer.
Sun C; Li B; Wei G; Qiu W; Li D; Li X; Liu X; Wei W; Wang S; Liu Z; Tian J; Liang L
Comput Methods Programs Biomed; 2022 Jun; 221():106914. PubMed ID: 35640390
[TBL] [Abstract][Full Text] [Related]
54. Identification and Validation of EMT-Related lncRNA Prognostic Signature for Colorectal Cancer.
Li D; Lin X; Chen B; Ma Z; Zeng Y; Wang H
Front Genet; 2021; 12():723802. PubMed ID: 34659346
[No Abstract] [Full Text] [Related]
55. CRC-113 gene expression signature for predicting prognosis in patients with colorectal cancer.
Nguyen MN; Choi TG; Nguyen DT; Kim JH; Jo YH; Shahid M; Akter S; Aryal SN; Yoo JY; Ahn YJ; Cho KM; Lee JS; Choe W; Kang I; Ha J; Kim SS
Oncotarget; 2015 Oct; 6(31):31674-92. PubMed ID: 26397224
[TBL] [Abstract][Full Text] [Related]
56. An EMT-related gene signature for the prognosis of human bladder cancer.
Cao R; Yuan L; Ma B; Wang G; Qiu W; Tian Y
J Cell Mol Med; 2020 Jan; 24(1):605-617. PubMed ID: 31657881
[TBL] [Abstract][Full Text] [Related]
57. Comprehensive Analysis of Gene Expression Profiles Identifies a
Chen Z; Chen M; Xue Z; Zhu X
Cancer Biother Radiopharm; 2021 Oct; 36(8):693-704. PubMed ID: 34520234
[No Abstract] [Full Text] [Related]
58. Improving the overall survival prognosis prediction accuracy: A 9-gene signature in CRC patients.
Zheng W; Lu Y; Feng X; Yang C; Qiu L; Deng H; Xue Q; Sun K
Cancer Med; 2021 Sep; 10(17):5998-6009. PubMed ID: 34346563
[TBL] [Abstract][Full Text] [Related]
59. Transcriptomic profiling of adjuvant colorectal cancer identifies three key prognostic biological processes and a disease specific role for granzyme B.
Daemen A; Udyavar AR; Sandmann T; Li C; Bosch LJW; O'Gorman W; Li Y; Au-Yeung A; Takahashi C; Kabbarah O; Bourgon R; Hegde P; Bais C; Das Thakur M
PLoS One; 2021; 16(12):e0262198. PubMed ID: 34972191
[TBL] [Abstract][Full Text] [Related]
60. A TMEFF2-regulated cell cycle derived gene signature is prognostic of recurrence risk in prostate cancer.
Georgescu C; Corbin JM; Thibivilliers S; Webb ZD; Zhao YD; Koster J; Fung KM; Asch AS; Wren JD; Ruiz-Echevarría MJ
BMC Cancer; 2019 May; 19(1):423. PubMed ID: 31060542
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]